These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21385076

  • 1. Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.
    Calvi L, Daniels GH.
    Thyroid; 2011 Apr; 21(4):443-9. PubMed ID: 21385076
    [Abstract] [Full Text] [Related]

  • 2. Lithium toxicity precipitated by thyrotoxicosis due to silent thyroiditis: cardiac arrest, quadriplegia, and coma.
    Sato Y, Taki K, Honda Y, Takahashi S, Yoshimura A.
    Thyroid; 2013 Jun; 23(6):766-70. PubMed ID: 23206122
    [Abstract] [Full Text] [Related]

  • 3. Ipodate therapy in patients with severe destruction-induced thyrotoxicosis.
    Arem R, Munipalli B.
    Arch Intern Med; 2013 Jun; 156(15):1752-7. PubMed ID: 8694676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Silent thyroiditis.
    Sakiyama R.
    J Fam Pract; 1986 Oct; 23(4):367-9. PubMed ID: 3760800
    [Abstract] [Full Text] [Related]

  • 8. [Current issues in the treatment of thyrotoxicosis].
    Papi G.
    Recenti Prog Med; 2005 Nov; 96(11):560-5. PubMed ID: 16499167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrent silent thyroiditis: a report of four patients and review of the literature.
    Mittra ES, McDougall IR.
    Thyroid; 2007 Jul; 17(7):671-5. PubMed ID: 17696838
    [Abstract] [Full Text] [Related]

  • 15. Transient thyrotoxicosis associated with painless thyroiditis and low radioactive iodine uptake.
    Inada M, Nishikawa M, Oishi M, Kurata S, Imura H.
    Arch Intern Med; 1979 May; 139(5):597-9. PubMed ID: 443958
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy.
    Minelli R, Girasole G, Pedrazzoni M, Giuliani N, Schianchi C, Giuberti T, Braverman LE, Salvi M, Roti E.
    J Investig Med; 1996 Aug; 44(6):370-4. PubMed ID: 8795300
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
    Dietlein M, Schicha H.
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
    [Abstract] [Full Text] [Related]

  • 19. Images in endocrine pathology: thyrotoxicosis associated with destructive thyroiditis.
    Mete O, Asa SL.
    Endocr Pathol; 2012 Sep; 23(3):212-4. PubMed ID: 22585443
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.